Skip to main content


Fig. 3 | BMC Cancer

Fig. 3

From: Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

Fig. 3

Inter-patient variation for the FLICA and γH2AX assays in the Trans-NCC0901 cohort. Inter-patient variation in %FLICA0Gy and %FLICA8Gy assay readouts for (a) the overall lymphocyte population, and b CD4+ and CD8+ lymphocyte sub-populations; Data-points represent mean of duplicate %FLICA0Gy and %FLICA8Gy readouts; solid dash lines indicate median for each subgroup. c γH2AX foci levels scored for 1 Gy 0.5 h and 4 Gy 24 h dose- and time-points for all patients. Solid dash lines indicate the median

Back to article page